Two Sigma Advisers’s ClearPoint Neuro CLPT Stock Holding History

Two Sigma Advisers’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-72,300	Closed	-$989K	–	442
2025 Q4	$989K	Sell	72,300 -60,100	-45%	-$1.11M	﹤0.01%	1485
2025 Q3	$2.88M	Buy	+132,400	New	+$1.56M	0.01%	965
2022 Q1	–	Sell	-58,100	Closed	-$652K	–	2761
2021 Q4	$652K	Buy	+58,100	New	+$870K	﹤0.01%	1776

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Two Sigma Advisers's CLPT Position: Q1 2026 in Review

Two Sigma Advisers sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 72,300 shares — an estimated $989K sold.

Two Sigma Advisers first reported a position in CLPT in Q4 2021 and held it in 3 quarters. The position peaked at $2.88M in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

Two Sigma Advisers reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 72,300 ClearPoint Neuro shares in Q1 2026, an estimated $989K.
Two Sigma Advisers first reported a position in ClearPoint Neuro in Q4 2021 and held it in 3 quarters.
Two Sigma Advisers's ClearPoint Neuro position peaked at $2.88M in Q3 2025.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.